|
KMID : 1144820200260010008
|
|
대한의생명과학회지
2020 Volume.26 No. 1 p.8 ~ p.13
|
|
|
Diagnostic Value of miR-1260b in Cervical Cancer: A Pilot Study
|
|
Kim Jung-Ho
Park Sun-Young
Lee Hye-Young
|
|
|
Abstract
|
|
|
|
Cervical cancer is the fourth most common cancer in women, with approximately 528,000 new cases and 266,000 women dying of it per year in the world. MicroRNAs have recently been in the spotlight as potential biomarkers that regulate gene expression and are involved in tumorigenesis. In the present study, we evaluated miR-1260b as a potential biomarker for screening of cervical cancer by quantitative reverse transcription PCR. We profiled the TCGA data of miR-1260b in 307 cervical cancer tissues. Then, miR-1260b expression levels in 10 cervical cancer tissues and 10 noncancerous tissues were investigated in a pilot study. miR-1260b was found to be significantly up-regulated in cervical cancer FFPE tissues as compared to those in cervical normal FFPE tissues (P = 0.006). The mean expression level of miR-1260b in late-stage (IIB-IVB) was higher than in those with early-stage (IA-IIA). Furthermore, high miR-1260b was found to be associated with high hTERT and Ki-67 mRNA expression, which are representative of tumor prognosis. The results of the pilot study suggest that miR-1260b may be used as a novel biomarker for improving the diagnosis of cervical cancer.
|
|
|
KEYWORD
|
|
|
Cervical cancer, miR-1260b, RT-qPCR
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|